Patents by Inventor Michael Luttrell

Michael Luttrell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Devices and methods for cornea treatment
    Patent number: 12102598
    Abstract: Medical devices and methods of use thereof are described. The device may include a body having a housing that defines a lumen, a piston within the housing, and an actuator operably coupled to the piston, wherein the piston is movable along the lumen by operating the actuator. The device also may include a cartridge insertable into the body and/or a flexible fitting configured for direct application to an eye of a subject.
    Type: Grant
    Filed: February 16, 2024
    Date of Patent: October 1, 2024
    Assignee: D&D Biopharmaceuticals, Inc.
    Inventors: Bruce H. DeWoolfson, Dale P. DeVore, Michael Luttrell, Chris L. Davis
  • Devices and methods for cornea treatment
    Patent number: 11938092
    Abstract: Medical devices and methods of use thereof are described. The device may include a body having a housing that defines a lumen, a piston within the housing, and an actuator operably coupled to the piston, wherein the piston is movable along the lumen by operating the actuator. The device also may include a cartridge insertable into the body and/or a flexible fitting configured for direct application to an eye of a subject.
    Type: Grant
    Filed: November 30, 2022
    Date of Patent: March 26, 2024
    Assignee: D&D Biopharmaceuticals, Inc.
    Inventors: Bruce H. DeWoolfson, Dale P. DeVore, Michael Luttrell, Chris L. Davis
  • Devices and methods for cornea treatment
    Patent number: 11259959
    Abstract: Medical devices and methods of treating subjects using such medical devices are described. The medical device may include a housing with at least two chambers including a first chamber adjacent to a second chamber; a barrier between the first chamber and the second chamber; and a soft, flexible base. The first and second chambers may be airtight, the barrier configured to establish fluid communication between the first chamber and the second chamber upon an application of force to the barrier.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: March 1, 2022
    Assignee: D&D Biopharmaceuticals, Inc.
    Inventors: Bruce H. DeWoolfson, Dale P. DeVore, Michael Luttrell
  • Chelator-functionalized nanoparticles
    Patent number: 8147802
    Abstract: Provided herein are chelator-functionalized nanoparticles comprising a passive core; and an active coating that demonstrate T1 magnetic resonance pattern upon exposure to a magnetic field. Also provided are methods of making such chelator-functionalized nanoparticles as well as imaging methods using the nanoparticles.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: April 3, 2012
    Assignee: General Electric Company
    Inventors: Zhebo Ding, Brian James Grimmond, Michael Luttrell, Slawomir Rubinsztajn, David Cheney deMoulpied, Margaret L. Blohm
  • CHELATOR-FUNCTIONALIZED NANOPARTICLES
    Publication number: 20090087381
    Abstract: Provided herein are chelator-functionalized nanoparticles comprising a passive core; and an active coating that demonstrate T1 magnetic resonance pattern upon exposure to a magnetic field. Also provided are methods of making such chelator-functionalized nanoparticles as well as imaging methods using the nanoparticles.
    Type: Application
    Filed: September 28, 2007
    Publication date: April 2, 2009
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Zhebo Ding, Brian James Grimmond, Michael Luttrell, Slawomir Rubinsztajn, David Cheney deMoulpied, Margaret L. Blohm